Microvascular inflammation in the kidney transplant, beyond acute antibody-mediated rejection
MVI represents a heterogeneous spectrum of alloimmune injuries that extends beyond the traditional AMR framework. Combining histology with emerging artificial intelligence tools, molecular diagnostics, and noninvasive biomarkers, will offer a more integrated approach to diagnosis, risk stratification, and development of novel therapies.
Authors
- Aurélie Sannier (ORCID: https://orcid.org/0000-0003-3973-8793)
- Alexandre Loupy (ORCID: https://orcid.org/0000-0003-3388-7747)
- Louise Benning (ORCID: https://orcid.org/0000-0002-8366-2100)
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Sorbonne Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
Publication Details
- Journal
- Current Opinion in Nephrology & Hypertension
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1097/mnh.0000000000001165
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00